ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Biotech CEO Bets Big, NVDA Insiders Cash Out

By ORTEX News · Edited by , Editor, ORTEX News1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Insider filings this week reveal a striking split in confidence across sectors.

SMMT Chairman and CEO Robert Duggan filed on June 12 disclosing a $50M personal purchase of 3.81 million shares at $13.12. That is the single largest US C-level buy filed in the past two weeks. He was not alone. President Maky Zanganeh and CFO Manmeet Soni both bought shares on June 4, adding $1.46M and $0.72M respectively. Three executives buying in the same week signals strong internal confidence at the clinical-stage biotech.

The picture looks very different at NVDA. Independent Director Mark Stevens filed sales of $221M across June 2–4, unloading 1 million shares near the $220 mark. Chairman Emeritus Stephen Neal added another $3.3M sale on June 3. Combined, NVIDIA insiders sold over $224M in a single week.

Meanwhile, ACS CEO Florentino Perez filed disclosures this week covering three separate purchases made in late December 2025. The total came to over $18M. The delayed filing bundles trades from December 23, 29, and 30. That is a notable late disclosure of persistent buying by the construction giant's chief executive.

The Walton Family Holdings Trust also filed a $184M WMT sale on June 4, continuing the family's pattern of routine stake reductions in Walmart.

This is not financial advice.

Stocks in this article

How this article was generated

Generated
17 Jun 2026, 20:14
Prompt version
v1.0
Data sources
Institutional positioning

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.